2014
DOI: 10.1016/j.tet.2013.12.005
|View full text |Cite
|
Sign up to set email alerts
|

Neomerane-type sesquiterpenoids from Valeriana officinalis var. latifolia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(9 citation statements)
references
References 13 publications
0
9
0
Order By: Relevance
“…The result suggested that V. officinalis extract was effective in modulating LPO induced by different pro-oxidant agents and because of that V. officinalis extract, functioning as an antioxidant agent, can be beneficial for reducing insomnia complications linked to oxidative stress [73]. peptide 25-35 (Aß [25][26][27][28][29][30][31][32][33][34][35] ). Cultured rat hippocampal neurons were exposed to Aß (25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35)) (25 µM) for 24-48 h, after which morphological and biochemical properties were evaluated.…”
Section: Pharmacological Activitymentioning
confidence: 99%
See 1 more Smart Citation
“…The result suggested that V. officinalis extract was effective in modulating LPO induced by different pro-oxidant agents and because of that V. officinalis extract, functioning as an antioxidant agent, can be beneficial for reducing insomnia complications linked to oxidative stress [73]. peptide 25-35 (Aß [25][26][27][28][29][30][31][32][33][34][35] ). Cultured rat hippocampal neurons were exposed to Aß (25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35)) (25 µM) for 24-48 h, after which morphological and biochemical properties were evaluated.…”
Section: Pharmacological Activitymentioning
confidence: 99%
“…peptide 25-35 (Aß [25][26][27][28][29][30][31][32][33][34][35] ). Cultured rat hippocampal neurons were exposed to Aß (25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35)) (25 µM) for 24-48 h, after which morphological and biochemical properties were evaluated. The neuronal injury (decrease in cell reducing capacity and associated neuronal degeneration) evoked by Aß, and prevented by valerian extract.…”
Section: Pharmacological Activitymentioning
confidence: 99%
“…Han et al isolated valeneomerins A-D, two unique neomerane-type sesquiterpenoids and two newer nor-sesquiterpenoids from the roots of V. officinalis. Their structures were characterized by elaborate spectroscopic analysis and Cu Ka X-ray crystallography [31]. Mirzaei and Dinpanah examined the applicability of hollow fiber-based liquid phase microextraction for the extraction and pre-concentration of valerenic acid earlier to its identification by reversed-phase high-performance liquid chromatography/ultraviolet [44].…”
Section: Phytochemistrymentioning
confidence: 99%
“…The result suggested that V. officinalis extract was effective in modulating LPO induced by different pro-oxidant agents and because of that V. officinalis extract, functioning as an antioxidant agent, can be beneficial for reducing insomnia complications linked to oxidative stress [73]. Fachinetto [25][26][27][28][29][30][31][32][33][34][35] ). Cultured rat hippocampal neurons were exposed to Aß (25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35) (25 µM) for 24-48 h, after which morphological and biochemical properties were evaluated.…”
Section: Pharmacological Activitymentioning
confidence: 99%
See 1 more Smart Citation